Not Finished Until Cancer Is
Moffitt Cancer Center’s surgical experts are leading the way in cutting-edge research, driving innovations that advance cancer diagnosis, prevention, and treatment. At the 2026 Society of Surgical Oncology Advanced Cancer Therapies (SSO ACT) Meeting, our faculty will showcase their pioneering work through poster sessions, presentations, and expert-led discussions, highlighting studies that are shaping the future of surgical oncology.
Join us to learn from Moffitt’s cancer specialists and see how our groundbreaking research is translating into improved outcomes for patients worldwide.
Meet the Moffitt Faculty and Trainees at ACT
Jonathan Zager, MD, FACS, FSSO
Chief Academic Officer
Director of Regional Therapies
Senior Member, Departments of Cutaneous Oncology and Sarcoma, Moffitt Cancer Center
Chair, Department of Oncologic Sciences, USF Morsani College of Medicine
Professor of Surgery, USF Morsani College of Medicine
Lacey Mead, DO, MS
Surgical Oncology Research Fellow
Solomon Alhassan, PhD
Caitlyn Balsay Patel, MD
Surgical Oncology Research Fellow
Nazanin Khajoueinejad, MD
Sean Dineen, MD, MHPE
Senior Member, Department of GI Surgical Oncology and Endoscopy
Peritoneal Disease Team Leader
Program Director, CGSO Fellowship
Moffitt Presentations
-
Saturday, February 14, 2026
Workshop: Great Debate: Fad or Future (Non-CME)
Saturday, February 14 | 2:15 - 3:50pmPercutaneous Hepatic Perfusion - FUTURE
Solomon Alhassan, PhDImmune Landscape and Molecular Heterogeneity in Appendiceal Cancers
Saturday, February 14 | 1:17 - 1:26pmWorkshop: Tools for Managing Advance PSM in - Patient Selection, Goals of Care, Treatment (Non-CME)
Saturday, February 14 | 2:15 - 3:50pmDiscussion & Case Presentations: Approaches: How to Develop Multi-institutional Collaboration in this Space?
-
Sunday, February 15, 2026
Symposia: Appendix PSM: The Most Challenging Bits
Sunday, February 15 | 9:00 - 10:00amHigh Grade Appendix - Bad Actors: Goblet & Signet Cell: Role of NAC vs. Upfront Surgery, Adjuvant Chemotherapy
-
Monday, February 16, 2026
Symposia: How do we sequence novel therapies for advanced melanoma?
Monday, February 16 | 8:30 - 9:30amSurgery/ILI/ILP
Caitlyn Balsay-Patel, MD, MSPercutaneous versus isolated hepatic perfusion for metastatic uveal melanoma: a propensity score-matched analysis
Monday, February 16 | 8:26 - 8:35am
Lacey Mead, DO, MSOutcomes of Percutaneous Hepatic Perfusion with Melphalan for Metastatic Uveal Melanoma to the Liver: Post-FDA Approval Real World Data
Monday, February 16 | 8:53 - 9:02am
Nazanin Khajoueinejad, MDPalliative Resection of Bulky Adnexal Disease Provides Symptomatic Benefit for Patients with Peritoneal Metastasis
Monday, February 16 | 11:14 - 11:23am -
Posters & ePosters
EP9: Survival and recurrence outcomes for stage IIB/IIC melanoma: risk stratification for immunotherapy and surveillance. Primary Presenter: Caitlyn Balsay-Patel, MD, MS
EP14: Favorable Long-Term Safety of Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma. Primary Presenter: Caitlyn Balsay-Patel, MD, MS
EP19: Manufacturing Success rate following tumor harvest for tumor infiltrating lymphocyte therapy from acral and mucosal melanoma subtypes. Primary Presenter: Lacey Mead, DO
EP21: Appraising the Role of Laparoscopy for Peritoneal Surface Malignancy Assessment: A Retrospective Cohort Study. Primary Presenter: Samantha Seitter, DO.
EP27: Abdominal Wall resections in Peritoneal Surface Malignancies: Outcomes and Durability in a Curative and Palliative Approach. Primary Presenter: Kevin Turner, MD
Jonathan S. Zager, MD, FACS, FSSO
Press Contact
Connect with Us
Follow Moffitt on X and LinkedIn for live coverage of the Meeting.
